Open original FDA record ↗Recall record
- FDA identifier
- Z-1209-03
- Company in FDA record
- bioMerieux
- FDA classification date
- Oct 15, 2003
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Product's decrease in sensitivity may result in false negative results
Source facts
- Action
- On August 6, 2003, Biomerieux''s recall letter and customer response form was sent to all US Customers and Biomerieux Global Customer Service in France, who is responsible for notification to all non-US bioMerieux subsidiaries. Non-US subsidiaries/distributors are responsible for notifying non-US Customers. VIDAS Chlamydia (CHL) Assay (product number 30 101) with Lot numbers 040212-0 and 040218-0 will be destroyed in the field.
- Initiated
- 2003-08-06
- Root cause
- Other
- Terminated
- 2005-05-17
- Distribution
- Nationwide NY, PA, IL, NJ, MO, NJ, NC, MI, WV, MD, CA, IN, MN, FL, WA, KS, GA, AZ, IA, SD, WI, SC, MT, TX, AK, OK, VA, CO, AL, OH, AR, MA, ND, CT, HI International: Japan, Argentina, Brazil, Chile, China, Columbia, Korea, Mexico, Canada, SA
- Recall number
- Z-1209-03
- Recall status
- Terminated
- CDRH record ID
- 28832
- FDA classified
- 2003-10-15
- Recall event number
- 26945